These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 367490)

  • 1. Determinants of immunity to influenza infection in man.
    Potter CW; Oxford JS
    Br Med Bull; 1979 Jan; 35(1):69-75. PubMed ID: 367490
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of specific immunity to viral neuraminidase on subsequent influenza virus infection in man.
    Yamane N; Odagiri T; Arikawa J; Kumasaka M; Ishida N
    Microbiol Immunol; 1979; 23(6):565-7. PubMed ID: 491992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complex study of population immunity to 3 influenza A virus antigens].
    Naĭkhin AN; Topuriia NV; Ismagulov AT; Denisov GM; Tsaritsyna IM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Feb; (2):77-81. PubMed ID: 7245959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological evidence of human infections with avian influenza viruses. Brief report.
    Profeta ML; Palladino G
    Arch Virol; 1986; 90(3-4):355-60. PubMed ID: 3729733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigenic-genetic connections between human and animal influenza viruses].
    Rovnova ZI; Isaeva EI; Platonova AL; Kosiakov PN
    Vopr Virusol; 1989; 34(5):553-7. PubMed ID: 2481903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies.
    Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S
    Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 9. A universal problem.
    Hoag H
    Nat Med; 2013 Jan; 19(1):12-4. PubMed ID: 23295998
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity to influenza.
    Schild GC; Oxford JS; Virelizier JL
    Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of a study of collective immunity to influenza A virus (H1N1) from 1976 to 1980].
    Naĭkhin AN; Denisov GM; Ivannikov IuG; Lisok TP; Oleĭnikova EV
    Vopr Virusol; 1981; (5):553-7. PubMed ID: 7336683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of antibodies to both hemagglutinin and neuraminidase antigens of H3N2 influenza A virus in domestic dogs.
    Kilbourne ED; Kehoe JM
    Intervirology; 1975-1976; 6(4-5):315-8. PubMed ID: 1235862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cell-mediated immune response to influenza virus. II. Experiments in ferrets.
    Semkow R; Loza-Tulimowska M; Brydak L; Zgorzelska K; Wilczyński J; Sadowski W
    Acta Microbiol Pol; 1982; 31(2):195-202. PubMed ID: 6188342
    [No Abstract]   [Full Text] [Related]  

  • 15. [Basic characteristics of a live influenza vaccine for children from type A influenza (H1N1 and H3N2) used separately and in combination].
    Rudenko LG; Shvartsman IaS; Ispolatova AV; Grigor'eva EP; Drinevskiĭ VP
    Vopr Virusol; 1989; 34(1):29-34. PubMed ID: 2728404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera.
    Styk B; Russ G; Poláková K
    Acta Virol; 1979 Jan; 23(1):1-8. PubMed ID: 35954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.
    Johansson BE; Moran TM; Bona CA; Popple SW; Kilbourne ED
    J Immunol; 1987 Sep; 139(6):2010-4. PubMed ID: 3624874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic and genetic conservation of the haemagglutinin in H1N1 swine influenza viruses.
    Noble S; McGregor MS; Wentworth DE; Hinshaw VS
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1197-200. PubMed ID: 8389804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of envelope antigens of influenza A (H3N2) virus isolated during 1983-1985 epidemics and from sporadic cases of infection.
    Stumpa A; Tůmová B; Luther P
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):173-80. PubMed ID: 3411119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.